Literature DB >> 35713174

Payer-negotiated pricing of the hypoglossal nerve stimulator.

Ryan A Bartholomew1, Mario V Russo2, Roy Xiao1, Vinay K Rathi1, Afash Haleem1, Phillip A Huyett1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35713174      PMCID： PMC9435329          DOI： 10.5664/jcsm.10142

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.324


× No keyword cloud information.
  6 in total

1.  Quantifying opportunities for hospital cost control: medical device purchasing and patient discharge planning.

Authors:  James C Robinson; Timothy T Brown
Journal:  Am J Manag Care       Date:  2014-09-01       Impact factor: 2.229

2.  Use and Cost of a Hypoglossal Nerve Stimulator Device for Obstructive Sleep Apnea Between 2015 and 2018.

Authors:  Vinay K Rathi; Neil S Kondamuri; Matthew R Naunheim; Shekhar K Gadkaree; Ralph B Metson; George A Scangas
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-10-01       Impact factor: 6.223

3.  Difference Between Estimated Purchase Price and Insurance Payments for Knee and Hip Implants in Privately Insured Patients Younger Than 65 Years.

Authors:  Yi-Ju Tseng; Kenneth D Mandl
Journal:  JAMA       Date:  2017-02-28       Impact factor: 56.272

4.  Cost of Joint Replacement Using Bundled Payment Models.

Authors:  Amol S Navathe; Andrea B Troxel; Joshua M Liao; Nan Nan; Jingsan Zhu; Wenjun Zhong; Ezekiel J Emanuel
Journal:  JAMA Intern Med       Date:  2017-02-01       Impact factor: 21.873

5.  Why Is Aducanumab Priced at $56,000 per Patient? Lessons for Drug-Pricing Reform.

Authors:  James C Robinson
Journal:  N Engl J Med       Date:  2021-11-20       Impact factor: 91.245

6.  Payer-Negotiated Prices in the Diagnosis and Management of Thyroid Cancer in 2021.

Authors:  Roy Xiao; Vinay K Rathi; Cary P Gross; Joseph S Ross; Rosh K V Sethi
Journal:  JAMA       Date:  2021-06-04       Impact factor: 56.272
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.